JP2002505442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002505442A5 JP2002505442A5 JP2000534679A JP2000534679A JP2002505442A5 JP 2002505442 A5 JP2002505442 A5 JP 2002505442A5 JP 2000534679 A JP2000534679 A JP 2000534679A JP 2000534679 A JP2000534679 A JP 2000534679A JP 2002505442 A5 JP2002505442 A5 JP 2002505442A5
- Authority
- JP
- Japan
- Prior art keywords
- separation
- data
- quality
- peak
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000926 separation method Methods 0.000 description 106
- 238000000034 method Methods 0.000 description 60
- 238000004458 analytical method Methods 0.000 description 40
- 238000013441 quality evaluation Methods 0.000 description 24
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 238000001514 detection method Methods 0.000 description 14
- 238000013442 quality metrics Methods 0.000 description 14
- 238000003556 assay Methods 0.000 description 11
- 238000001962 electrophoresis Methods 0.000 description 11
- 239000012491 analyte Substances 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 7
- 238000005251 capillar electrophoresis Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000012252 genetic analysis Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 238000012443 analytical study Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000012254 genetic linkage analysis Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 101150112095 map gene Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 208000030683 polygenic disease Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000238 shellfish toxin Substances 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/036,767 | 1998-03-06 | ||
| US09/036,767 US6019896A (en) | 1998-03-06 | 1998-03-06 | Method for using a quality metric to assess the quality of biochemical separations |
| PCT/US1999/004246 WO1999045148A1 (en) | 1998-03-06 | 1999-02-25 | Method for using a quality metric to assess the quality of biochemical separations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002505442A JP2002505442A (ja) | 2002-02-19 |
| JP2002505442A5 true JP2002505442A5 (https=) | 2009-04-23 |
| JP4360479B2 JP4360479B2 (ja) | 2009-11-11 |
Family
ID=21890529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534679A Expired - Fee Related JP4360479B2 (ja) | 1998-03-06 | 1999-02-25 | 生化学分離の品質の評価に品質評価基準を用いる方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6019896A (https=) |
| EP (1) | EP1070142B1 (https=) |
| JP (1) | JP4360479B2 (https=) |
| AT (1) | ATE388240T1 (https=) |
| DE (1) | DE69938296T2 (https=) |
| WO (1) | WO1999045148A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136541A (en) | 1999-02-22 | 2000-10-24 | Vialogy Corporation | Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions |
| US6142681A (en) | 1999-02-22 | 2000-11-07 | Vialogy Corporation | Method and apparatus for interpreting hybridized bioelectronic DNA microarray patterns using self-scaling convergent reverberant dynamics |
| US20030170734A1 (en) * | 2000-04-28 | 2003-09-11 | Stephen Williams | Multiplexed assays using electrophoretically separated molecular tags |
| JP2004516455A (ja) * | 2000-07-21 | 2004-06-03 | アプレラ コーポレイション | 生物学的データを評価するための方法、システム、および製品 |
| US20020116135A1 (en) * | 2000-07-21 | 2002-08-22 | Pasika Hugh J. | Methods, systems, and articles of manufacture for evaluating biological data |
| GB0119959D0 (en) * | 2001-08-16 | 2001-10-10 | Sec Dep Of The Home Department | Improvements in and relating to analysis |
| SE0200949D0 (sv) * | 2002-03-27 | 2002-03-27 | Biacore Ab | Method and system for curve quality control |
| WO2003085374A2 (en) * | 2002-04-02 | 2003-10-16 | Aclara Biosciences, Inc. | Multiplexed assays using electrophoretically separated molecular tags |
| DE10315581B4 (de) * | 2003-04-05 | 2007-06-28 | Agilent Technologies, Inc. (n.d.Ges.d.Staates Delaware), Palo Alto | Verfahren zur Qualitätsbestimmung von RNA-Proben |
| WO2006130165A2 (en) | 2004-09-02 | 2006-12-07 | Vialogy Corp. | Detecting events of interest using quantum resonance interferometry |
| GB0419482D0 (en) * | 2004-09-02 | 2004-10-06 | Sec Dep For The Home Departmen | Improvements in and relating to analysis |
| JP2006230917A (ja) * | 2005-02-28 | 2006-09-07 | Kaoru Imaoka | 重心動揺計および重心動揺特性評価方法 |
| US7799527B2 (en) * | 2005-07-01 | 2010-09-21 | Illumina, Inc. | Systems and methods for automated quality control of polymer synthesis |
| US10488393B2 (en) | 2010-09-30 | 2019-11-26 | Robert Bosch Gmbh | Device and method for self-referenced confidence test |
| US20140149050A1 (en) * | 2011-07-08 | 2014-05-29 | Shimadzu Corporation | Data processing system for chromatograph |
| WO2013077864A1 (en) * | 2011-11-22 | 2013-05-30 | Robert Bosch Gmbh | Method for self-referenced confidence test |
| EP3742159A1 (en) * | 2019-05-24 | 2020-11-25 | Sartorius Stedim Biotech GmbH | Chromatography method, method of determining the influence of the interdependency of at least two parameters in a chromatography method and method of obtaining at least one chromatography method parameter |
| EP3742160B1 (en) | 2019-05-24 | 2023-08-09 | Sartorius Stedim Biotech GmbH | Chromatography method, method of determining the concentration of at least one compound in a chromatography method and method of obtaining at least one chromatography method parameter |
| US12594557B2 (en) | 2019-08-12 | 2026-04-07 | Intabio, Llc | Isoelectric focusing devices and fixtures |
| US11285484B2 (en) | 2019-08-12 | 2022-03-29 | Intabio, Llc | Multichannel isoelectric focusing devices and high voltage power supplies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0359320A3 (en) * | 1988-09-14 | 1991-10-23 | Philips Electronics Uk Limited | Chromatography apparatus |
| US5558998A (en) * | 1992-02-25 | 1996-09-24 | The Regents Of The Univ. Of California | DNA fragment sizing and sorting by laser-induced fluorescence |
| US5580728A (en) * | 1994-06-17 | 1996-12-03 | Perlin; Mark W. | Method and system for genotyping |
| US5604097A (en) * | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
| US6015667A (en) * | 1996-06-03 | 2000-01-18 | The Perkin-Emer Corporation | Multicomponent analysis method including the determination of a statistical confidence interval |
-
1998
- 1998-03-06 US US09/036,767 patent/US6019896A/en not_active Expired - Lifetime
-
1999
- 1999-02-25 WO PCT/US1999/004246 patent/WO1999045148A1/en not_active Ceased
- 1999-02-25 DE DE69938296T patent/DE69938296T2/de not_active Expired - Lifetime
- 1999-02-25 AT AT99909649T patent/ATE388240T1/de not_active IP Right Cessation
- 1999-02-25 EP EP99909649A patent/EP1070142B1/en not_active Expired - Lifetime
- 1999-02-25 JP JP2000534679A patent/JP4360479B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4360479B2 (ja) | 生化学分離の品質の評価に品質評価基準を用いる方法 | |
| JP2002505442A5 (https=) | ||
| Mueller et al. | RNA integrity number (RIN)–standardization of RNA quality control | |
| Terp et al. | Extraction of cell-free DNA: evaluation of efficiency, quantity, and quality | |
| Burns et al. | Measurement issues associated with quantitative molecular biology analysis of complex food matrices for the detection of food fraud | |
| CN112592965B (zh) | 一种TaqMan探针法的E.coli宿主DNA残留检测试剂盒 | |
| US20250084456A1 (en) | Barcoded molecular standards | |
| JP2008533558A (ja) | 遺伝子型分析のための正規化方法 | |
| Hawtin et al. | Utility of lab‐on‐a‐chip technology for high‐throughput nucleic acid and protein analysis | |
| Coşkun et al. | Electrophoresis applications used in medicine | |
| Alwi et al. | Internal validation of reduced PCR reaction volume of the Qiagen Investigator® Argus X‐12 QS Kit from blood samples on FTA cards | |
| JP3975663B2 (ja) | 遺伝子多型解析方法 | |
| WO2023021978A1 (ja) | 自己免疫疾患を検査する方法 | |
| JPH11118760A (ja) | 核酸断片の電気泳動パターンの解析法 | |
| Sari et al. | Detection of Porcine DNA in Cosmetic Products using Real-Time PCR Method: A Review of Method and Applications | |
| US20050014176A1 (en) | Method for quantitative end-point PCR | |
| CN115851934B (zh) | 一种单基因检测方法及其应用 | |
| EP2053401A1 (en) | A method for measuring the biological diversity of a sample | |
| JP2004526941A (ja) | 化学試料を分析するための装置および方法 | |
| Lin et al. | Automatic analysis for biochip based on macromolecular compound material | |
| Franjić | DNA profiling is an important forensic technique | |
| JP2009531037A (ja) | 混合試料の特性決定法 | |
| Bregu | Investigation of Baseline Noise: Establishing an RFU threshold for forensic DNA analysis | |
| Steinberg et al. | Assessing genotypes in human genome epidemiology studies | |
| CN121320551A (zh) | 一种基于纳米孔测序技术的动物种属鉴定方法及其应用 |